Smith & Nephew Forecasts FY28 Underlying Revenue, Trading Profit Growth

02:41 AM EST, 12/08/2025 (MT Newswires) -- Smith & Nephew (SN.L) on Monday provided its underlying revenue and trading profit guidance for 2028. The British medical technology company set a 6% to 7% target for compound annual growth rate in underlying revenue and a 9% to 10% range for its trading profit.